13-[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-4-one (173327-05-4)

Identification
Name:	13-[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-4-one
Synonyms:	Broussonetine C;SMR000232352;MLS000575017;AC1L42N4;HMS2194N18;NCGC00247566-01;13-[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-4-one;173327-05-4
CAS:	173327-05-4
Molecular Formula:	C₁₈H₃₅NO₅
Molecular Weight:	345.4742
InChI:	InChI=1/C18H35NO5/c20-12-8-10-14(22)9-6-4-2-1-3-5-7-11-15-17(23)18(24)16(13-21)19-15/h15-21,23-24H,1-13H2/t15-,16-,17-,18-/m1/s1
Molecular Structure:
Properties
Flash Point:	287.4°C
Boiling Point:	551.6°C at 760 mmHg
Density:	1.11g/cm³
Refractive index:	1.51
Flash Point:	287.4°C
Safety Data

Other Product

13-[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-5-one
4-Tridecanone, 13-((2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl)-1,13-dihydroxy-, (13R)-
(2R,3R,4R,5R)-4-(benzyloxy)-2-((benzyloxy)methyl)-5-(hydroxymethyl)pyrrolidin-3-ol
1-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-prop-2-enoxyoxolan-2-yl]-2-sulfanylidenepyrimidin-4-one
5-Tridecanone,13-[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]-1-(b-D-glucopyranosyloxy)-13-hydroxy-,(13R)-
1-[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboximidamide
1-[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide
1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-(pyridin-3-yloxy)pyrimidin-2(1H)-one
5-Tridecanone,13-[(2R,3R,4R,5R)-1-ethyl-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]-1,13-dihydroxy-, (13R)-
1-[(2R)-2-{(1S,2S)-8-[(3R,4R,5R)-1-acetyl-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,2-dihydroxyoctyl}piperidin-1-yl]ethanone
(3R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-2-(13-hydroxy-10-oxotridecyl)pyrrolidin-3-yl beta-D-glucopyranoside
[(1R)-1-[2-[(2R,3R,4R,5S,6R)-2-[[(3S,4R,5R,6S)-3,6-dihydroxy-5-[[(3R)-3-hydroxytetradecanoyl]amino]-4-[(3R)-3-hydroxytetradecanoyl]oxy-tetrahydropyran-2-yl]methoxy]-3-[[(3R)-3-dodecanoyloxytetradecanoyl]amino]-6-(hydroxymethyl)-5-phosphonooxy-tetrahydropy
5-Tridecanone,13-[(2R,3R,4R,5R)-1-ethyl-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]-1-hydroxy-
N-[(2R,3R,4R,5S,6R)-2-[(2R,3S,4R,5R)-4-[(2R,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-6-hydroxy-1-oxo-2-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyhexan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
1-Pyrrolidinecarboxylic acid,3,4-dihydroxy-2-(hydroxymethyl)-5-(13-hydroxy-10-oxotridecyl)-,1,1-dimethylethyl ester, (2R,3R,4R,5R)-
4-Tridecanone,13-[(2R,3R,4S,5R)-1-ethyl-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]-1-hydroxy-
4-amino-1-[(2R,3R,4R,5R)-3,4-difluoro-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidin-2-one
1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-(pyridin-2-ylthio)pyrimidin-2(1H)-one
9-[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-[(1,2,3-trihydroxy-1,2,3,4-tetrahydrochrysen-4-yl)amino]-3H-purin-6-one
1-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-4-imino-3-methyl-3,4-dihydropyrimidin-2(1H)-one